Chemomab Therapeutics Ltd. Profit Loss Before Tax
Chemomab Therapeutics Ltd. (CMMB) reported Profit Loss Before Tax of -$12.66 million for the 12-month period ending 2018-12-31, per its 20-F filed 2019-04-24.
Discontinued › Notes
ifrs-full:ProfitLossBeforeTax · last filed 2019-04-24
| Period end | Profit Loss Before Tax 12 month |
|---|---|
| 2018-12-31 | -$12.66M 20-F · filed 2019-04-24 |
| 2017-12-31 | -$9.48M 20-F · filed 2019-04-24 |
| 2016-12-31 | -$4.61M 20-F · filed 2019-04-24 |